Pfizer's dividend payout ratio of 122.5% looks concerning at first glance. A company can only pay out more in dividends than ...

I don't think so. A much better financial metric to consider when evaluating the sustainability of the dividend is free cash flow. Pfizer generated free cash flow of around $9.8 billion in 2024.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A high dividend yield can be enticing, but it can also raise flags for income investors. Pfizer's falling valuation has pushed its yield up to well over 7%, which warrants a closer look.

Consider that the average dividend yield for the S&P 500 (SNPINDEX: ^GSPC) is 1.3%, which is not particularly high. On May 20, BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer ...

Consider pharmaceutical giant Pfizer (NYSE: PFE). Its dividend yield is around 7.5% right now, and if the stock continues to decline, it may not be long before it hits 8%. The big question is ...

Sustainability of Pfizer's future cash flow significantly ... in PFE prior to the upcoming earnings release. A 7.5% forward dividend yield is absolutely a steal, especially keeping in mind ...

Dividend growth and low payout ratios are key for long-term compounding. Click here for more information on Dividend ...

If you really want to get exactly $10,000 in annual dividend income, though, you could use fractional shares. At Pfizer's share price at the time of this writing ($22.87), you'd need to invest ...